文献速递垂体与肾上腺疾病

亚临床原发性醛固酮增多症以利钠肽与肾上腺激素生理适应不良为特征

Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该研究前瞻性纳入75例血压正常者,经口服钠负荷后评估最大抑制状态下的血浆醛固酮以量化亚临床原发性醛固酮增多症(PA),并通过多种内分泌试验探讨其机制。结果显示亚临床PA程度越高,基础NT-proBNP越低、钠负荷后NT-proBNP刺激越钝化,且血管紧张素II依赖性和非依赖性醛固酮生成均增加,ACTH介导的醛固酮生成也平行加重。盐水抑制试验后24.2%的参与者醛固酮大于10 ng/dL,72.7%大于6 ng/dL,提示血压正常人群中存在显性PA病理生理。

要点

  • 亚临床PA程度与较低的基础NT-proBNP及钠负荷后NT-proBNP刺激钝化相关(P-trend分别<.01和=.023)。
  • 亚临床PA程度与更大的血管紧张素II依赖性和非依赖性醛固酮生成相关(P-trend均<.001)。
  • 盐水抑制试验后24.2%的参与者醛固酮大于10 ng/dL,72.7%大于6 ng/dL。

核心结论

  • 血压正常人群中亚临床PA的病理生理连续谱以利钠肽不足以及对血管紧张素II和ACTH的醛固酮反应增强为特征。

研究设计与样本

  • 前瞻性招募75例血压正常参与者,在口服钠负荷后维持仰卧位评估最大抑制状态下的血浆醛固酮。
  • 通过膳食钠调节、外源性血管紧张素II输注、盐水抑制试验、地塞米松抑制试验和ACTH刺激试验评估内分泌机制。

主要发现

  • 亚临床PA程度越大,基础NT-proBNP越低(P-trend<.01),钠负荷后NT-proBNP刺激越钝化(P-trend=.023)。
  • 亚临床PA程度与更大的血管紧张素II依赖性(P-trend<.001)和非依赖性(P-trend<.001)醛固酮生成相关。
  • 亚临床PA程度与ACTH介导的醛固酮生成严重程度平行(P-trends<.001)。
  • 盐水抑制试验后24.2%的参与者醛固酮大于10 ng/dL,72.7%的参与者醛固酮大于6 ng/dL。

关键数值与推荐

  • 盐水抑制试验后醛固酮大于10 ng/dL者占24.2%,大于6 ng/dL者占72.7%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: A continuum of non-suppressible aldosterone production has been demonstrated in normotensive individuals, termed subclinical primary aldosteronism (PA), and is consistently associated with increased risk for developing hypertension and cardiovascular disease. The hormonal mechanisms accounting for subclinical PA are not well understood. METHODS: To quantify the magnitude of subclinical PA, prospectively recruited normotensive participants (n = 75) had their maximally suppressed plasma aldosterone assessed after maintaining supine posture following an oral sodium loading protocol. To investigate the endocrine mechanisms involved with this continuum, multiple maneuvers were conducted to evaluate: (i) natriuretic peptide physiology (N-terminal pro B-type natriuretic peptide [NT-proBNP] suppression and stimulation using dietary sodium modulation); (ii) angiotensin II (AngII)-dependent aldosterone production (via dietary sodium restriction and via infusion of exogenous AngII); (iii) AngII-independent aldosterone production (via saline suppression test [SST]); and (iv) ACTH-mediated aldosterone production (via dexamethasone suppression test and ACTH-stimulation test). RESULTS: Greater magnitude of subclinical PA was associated with lower basal NT-proBNP (P-trend < .01) and blunted stimulation of NT-proBNP following sodium loading (P-trend = .023). The magnitude of subclinical PA was also associated with greater AngII-dependent (P-trend < .001) and AngII-independent (P-trend < .001) aldosterone production and paralleled the severity of ACTH-mediated aldosterone production (P-trends < .001). Following SST, 24.2% of participants had a post-saline aldosterone greater than 10 ng/dL and 72.7% had a post-saline aldosterone greater than 6 ng/dL, confirming that the continuum of subclinical PA included overt PA pathophysiology within these normotensive participants. CONCLUSION: These findings demonstrate that the pathophysiologic continuum of subclinical PA in normotensive people is characterized by natriuretic peptide insufficiency and heightened aldosterone responses to both AngII and ACTH. These early maladaptive hormonal changes provide mechanistic explanations for the role of subclinical PA in the pathogenesis of hypertension.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Parisien-La Salle S, Brown JM, Mahrokhian S, et al. Subclinical Primary Aldosteronism Is Characterized by Maladaptive Natriuretic Peptide and Adrenal Hormonal Physiology. J Clin Endocrinol Metab. 2025. PMID: 40036317. doi:10.1210/clinem/dgaf129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。